On 9-11 February 2026, PLAST_CELL was present at the society for Laboratory Automation and Screening (SLAS) 2026, the flagship international conference dedicated to life sciences discovery and laboratory automation, bringing together over 7,000 researchers and technology providers from academia and industry.

At the event, Cherry Biotech presented its latest innovations in organoid and organ-on-chip automation technologies, including the “Organoids Plate” platform. Within this framework, the PLAST_CELL project was highlighted through its work on AI-based morphodynamic quantification of breast cancer tumour cell aggressiveness, demonstrating how advanced imaging and analysis tools can contribute to more precise characterisation of tumour plasticity.

The participation in SLAS provided an excellent opportunity to engage with key stakeholders in the fields of laboratory automation, 3D cell culture, and translational oncology. Through discussions at the booth and networking activities, the project reinforced its visibility within an international ecosystem driving innovation in biomedical research and personalised medicine.

This presence contributes to the dissemination and exploitation objectives of PLAST_CELL by promoting its technological advances and fostering connections with both academic and industrial partners working at the forefront of next-generation cell-based models.

Jérémy Cramer at one of the booths in SLAS Annual Meeting in Boston, 9-11th February